Futreal PA - Search Results

1

Detection of BRCA1 mutations in women with early-onset ovarian cancer by use of the protein truncation test.

Lancaster JM, Cochran CJ, Brownlee HA, Evans AC, Berchuck A, Futreal PA, Wiseman RW. Lancaster JM, et al. Among authors: futreal pa. J Natl Cancer Inst. 1996 Apr 17;88(8):552-4. doi: 10.1093/jnci/88.8.552. J Natl Cancer Inst. 1996. PMID: 8606385 No abstract available.

2

BRCA2 mutations in primary breast and ovarian cancers.

Lancaster JM, Wooster R, Mangion J, Phelan CM, Cochran C, Gumbs C, Seal S, Barfoot R, Collins N, Bignell G, Patel S, Hamoudi R, Larsson C, Wiseman RW, Berchuck A, Iglehart JD, Marks JR, Ashworth A, Stratton MR, Futreal PA. Lancaster JM, et al. Among authors: futreal pa. Nat Genet. 1996 Jun;13(2):238-40. doi: 10.1038/ng0696-238. Nat Genet. 1996. PMID: 8640235

3

Characterization of the rat and mouse homologues of the BRCA2 breast cancer susceptibility gene.

McAllister KA, Haugen-Strano A, Hagevik S, Brownlee HA, Collins NK, Futreal PA, Bennett LM, Wiseman RW. McAllister KA, et al. Among authors: futreal pa. Cancer Res. 1997 Aug 1;57(15):3121-5. Cancer Res. 1997. PMID: 9242436

4

Dideoxy fingerprinting assay for BRCA1 mutation analysis.

Lancaster JM, Berchuck A, Futreal PA, Wiseman RW. Lancaster JM, et al. Among authors: futreal pa. Mol Carcinog. 1997 Jul;19(3):176-9. Mol Carcinog. 1997. PMID: 9254884

5

BRCA1 and BRCA2 in breast cancer families from Wales: moderate mutation frequency and two recurrent mutations in BRCA1.

Lancaster JM, Carney ME, Gray J, Myring J, Gumbs C, Sampson J, Wheeler D, France E, Wiseman R, Harper P, Futreal PA. Lancaster JM, et al. Among authors: futreal pa. Br J Cancer. 1998 Dec;78(11):1417-20. doi: 10.1038/bjc.1998.701. Br J Cancer. 1998. PMID: 9836472 Free PMC article.

6

Detection of frequent allelic loss on proximal chromosome 17q in sporadic breast carcinoma using microsatellite length polymorphisms.

Futreal PA, Söderkvist P, Marks JR, Iglehart JD, Cochran C, Barrett JC, Wiseman RW. Futreal PA, et al. Cancer Res. 1992 May 1;52(9):2624-7. Cancer Res. 1992. PMID: 1568230

7

Mutation analysis of the THRA1 gene in breast cancer: deletion/fusion of the gene to a novel sequence on 17q in the BT474 cell line.

Futreal PA, Cochran C, Marks JR, Iglehart JD, Zimmerman W, Barrett JC, Wiseman RW. Futreal PA, et al. Cancer Res. 1994 Apr 1;54(7):1791-4. Cancer Res. 1994. PMID: 7511052

8

BRCA1 mutations in primary breast and ovarian carcinomas.

Futreal PA, Liu Q, Shattuck-Eidens D, Cochran C, Harshman K, Tavtigian S, Bennett LM, Haugen-Strano A, Swensen J, Miki Y, et al. Futreal PA, et al. Science. 1994 Oct 7;266(5182):120-2. doi: 10.1126/science.7939630. Science. 1994. PMID: 7939630

9

Microsomal epoxide hydrolase polymorphism as a risk factor for ovarian cancer.

Lancaster JM, Brownlee HA, Bell DA, Futreal PA, Marks JR, Berchuck A, Wiseman RW, Taylor JA. Lancaster JM, et al. Among authors: futreal pa. Mol Carcinog. 1996 Nov;17(3):160-2. doi: 10.1002/(SICI)1098-2744(199611)17:3<160::AID-MC8>3.0.CO;2-J. Mol Carcinog. 1996. PMID: 8944076

10

Frequency of germline and somatic BRCA1 mutations in ovarian cancer.

Berchuck A, Heron KA, Carney ME, Lancaster JM, Fraser EG, Vinson VL, Deffenbaugh AM, Miron A, Marks JR, Futreal PA, Frank TS. Berchuck A, et al. Among authors: futreal pa. Clin Cancer Res. 1998 Oct;4(10):2433-7. Clin Cancer Res. 1998. PMID: 9796975

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

358 results

Search Page

Filters